VOLORIDGE INVESTMENT MANAGEMENT, LLC - CELLDEX THERAPEUTICS INC NEW ownership

Back to all holdings Add to watchlist

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 189 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2015. The put-call ratio across all filers is 1.49 and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
VOLORIDGE INVESTMENT MANAGEMENT, LLC ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2015$2,488,000
+24.3%
89,278
-21.2%
0.12%
-57.9%
Q1 2014$2,001,000–113,248–0.28%–
 Download
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q2 2015
NameSharesValueWeighting ↓
Byrne Asset Management LLC 86$2,0000.00%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders